HLA DR antigens and gold toxicity.
AUTOR(ES)
Gran, J T
RESUMO
One hundred and thirty-two patients with rheumatoid arthritis treated with gold have been studied for possible associations between HLA DR antigens and different adverse reactions occurring during such therapy. Patients possessing HLA DR3 had a significantly greater frequency of side effects than patients lacking this antigen. It was particularly noticed that DR3 positive patients on gold treatment had an 11 times higher risk of getting proteinuria than those without DR3. The lowest frequency of side effects was seen in DR7 positives. No significant differences between the DR antigen groups with respect to skin eruptions, liver reactions, or leucopenia were evident.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001062Documentos Relacionados
- Non-HLA antigens and HLA-DR matching in corneal transplantation.
- HLA DR antigens and disease expression in rheumatoid arthritis.
- Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.
- Delusions and cyclosporine toxicity.
- Drug toxicity.